![](https://img.etimg.com/thumb/msid-111638073,width-1070,height-580,imgsize-82416,overlay-ettech/photo.jpg)
Tata 1mg’s FY24 report; Cognizant-Wipro lawsuit settled
Epharmacy Tata 1mg reported a 21% rise in revenue to Rs 1,968 crore for FY24. This and more on today’s ETtech Top 5. Also in the letter: ■ Vyome Therapeutics' US listing ■ Adverse effects of Instagram Stories ■ Microsoft gives up OpenAI board seat Tata …